Circadian Extracellular Matrix Remodeling

Target: MMP9/HAS2 Composite Score: 0.455 Price: $0.52▲6.0% Citation Quality: Pending chronobiology Status: active

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

📄 Export → LaTeX

Select venue

arXiv Preprint NeurIPS Nature Methods PLOS ONE

🌐 Open in Overleaf →

📖 Export BibTeX

✓ All Quality Gates Passed

Evidence Strength Pending (0%)

Citations

Debates

Supporting

Opposing

Quality Report Card click to collapse

Composite: 0.455

Top 73% of 1875 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

C+ Mech. Plausibility 15% 0.50 Top 76%

C+ Evidence Strength 15% 0.50 Top 57%

C+ Novelty 12% 0.50 Top 82%

C+ Feasibility 12% 0.50 Top 65%

F Impact 12% 0.00 Top 50%

C+ Druggability 10% 0.50 Top 57%

C+ Safety Profile 8% 0.50 Top 57%

C+ Competition 6% 0.50 Top 77%

C+ Data Availability 5% 0.50 Top 71%

C+ Reproducibility 5% 0.50 Top 63%

Evidence

5 supporting | 3 opposing

Citation quality: 0%

Debates

1 session A+

Avg quality: 0.95

Convergence

0.00 F 6 related hypothesis share this target

From Analysis:

Can circadian interventions reverse microglial priming independent of sleep disruption effects?

The debate highlighted that sleep disruption affects multiple systems simultaneously, creating confounding variables. Isolating direct circadian effects on microglia from indirect sleep-related mechanisms is crucial for therapeutic specificity. Source: Debate session sess_SDA-2026-04-04-gap-neuroinflammation-microglial-20260404 (Analysis: SDA-2026-04-04-gap-neuroinflammation-microglial-20260404)

→ View full analysis & debate transcript

Description

Timed delivery of MMP inhibitors to modulate extracellular environment maintaining microglial priming, allowing circadian resolution pathways to predominate

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

8 citations 8 with PMID 8 medium Validation: 0% 5 supporting / 3 opposing

✓ For (5)

(3) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 3CLIN 4GENE 1EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
C9orf72-ALS human iPSC microglia are pro-inflammat…	Supporting	MECH	Nat Commun	MEDIUM	2023	-	PMID:37736756	-
CCL5/CCR5-mediated peripheral inflammation exacerb…	Supporting	MECH	J Transl Med	MEDIUM	2023	-	PMID:36918921	-
APOE4 derived from astrocytes leads to blood-brain…	Supporting	GENE	Brain	MEDIUM	2022	-	PMID:34957486	-
Neutrophil Integrin α9 Impairs Efferocytosis and W…	Supporting	MECH	Arterioscler Th…	MEDIUM	2025	-	PMID:40740133	-
Elevated blood and cerebrospinal fluid biomarkers …	Supporting	CLIN	J Neuroinflamma…	MEDIUM	2023	-	PMID:37481571	-
The Roles of Matrix Metalloproteinases and Their I…	Opposing	CLIN	Int J Mol Sci	MEDIUM	2020	-	PMID:33419373	-
Evolution of blood-brain barrier in brain diseases…	Opposing	CLIN	Acta Pharm Sin …	MEDIUM	2021	-	PMID:34522589	-
Metal Complexes as Promising Matrix Metalloprotein…	Opposing	CLIN	Int J Mol Sci	MEDIUM	2023	-	PMID:36674771	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 5

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9. MEDIUM

Nat Commun · 2023 · PMID:37736756

CCL5/CCR5-mediated peripheral inflammation exacerbates blood‒brain barrier disruption after intracerebral hemo… MEDIUM▼

CCL5/CCR5-mediated peripheral inflammation exacerbates blood‒brain barrier disruption after intracerebral hemorrhage in mice.

J Transl Med · 2023 · PMID:36918921

APOE4 derived from astrocytes leads to blood-brain barrier impairment. MEDIUM

Brain · 2022 · PMID:34957486

Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage. MEDIUM

Arterioscler Thromb Vasc Biol · 2025 · PMID:40740133

Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood‒brain barrier disruption … MEDIUM▼

Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood‒brain barrier disruption in anti-NMDA receptor encephalitis.

J Neuroinflammation · 2023 · PMID:37481571

✗ Opposing Evidence 3

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. MEDIUM

Int J Mol Sci · 2020 · PMID:33419373

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug deliver… MEDIUM▼

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.

Acta Pharm Sin B · 2021 · PMID:34522589

Metal Complexes as Promising Matrix Metalloproteinases Regulators. MEDIUM

Int J Mol Sci · 2023 · PMID:36674771

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-10 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

I notice that while you've mentioned there should be literature provided above about circadian interventions and microglial priming, I don't see any specific research papers, PMIDs, or figure evidence in your prompt. The knowledge gap you've described is fascinating - exploring whether circadian interventions can reverse microglial priming independently of their effects on sleep disruption.

Let me generate novel therapeutic hypotheses based on the general understanding of circadian biology and microglial function, and then I can search for specific supporting evidence if needed:

Novel The

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

I'll provide a rigorous scientific critique of each hypothesis, focusing on identifying weaknesses, gaps in evidence, and alternative explanations.

Critical Evaluation of Therapeutic Hypotheses

1. Clock Gene-Mediated Microglial Reprogramming

Confidence: 0.75 → Revised: 0.35

Weaknesses:

Cell-type specificity gap: No evidence that BMAL1/CLOCK can be selectively targeted in microglia without affecting other brain cells or peripheral tissues
Compensation mechanisms ignored: CLOCK/BMAL1 knockout studies show compensatory pathways (NPAS2 can substitute for CLOCK)
**De

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Clinical precedent:

Anti-TNF drugs have 20+ year safety record
IL-1 inhibitors approved and well-tolerated

Competitive advantage:

Chronotherapy approach could differentiate from continuous dosing
Lower overall drug exposure, potentially better safety

Timeline/Cost: 3-5 years, $200-500M (repurposing approved drugs)

7. Circadian Extracellular Matrix Remodeling

Druggability: MODERATE

Existing compounds:

MMP inhibitors: Marimastat (failed cancer trials), Batimastat (discontinued)
Hyaluronan therapies: Viscosupplementation products (orthopedics)

**H

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

7d Trend

↔

Stable

7d Momentum

▲ 7.4%

Volatility

High

0.0535

Events (7d)

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (8)

Paper:33419373

No extracted figures yet

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.

Acta pharmaceutica Sinica. B (2021) · PMID:34522589

No extracted figures yet

Paper:34957486

No extracted figures yet

Paper:36674771

No extracted figures yet

Paper:36918921

No extracted figures yet

Paper:37481571

No extracted figures yet

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9.

Nature communications (2023) · PMID:37736756

No extracted figures yet

Paper:40740133

No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (1)

📓 Can circadian interventions reverse microglial priming independent of sleep disruption effects? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-08-gap-debate-20260406-062033-16eccec1. The debate highlighted that sleep disruption affects multiple systems simultaneously, creating confounding v …

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score

0.50

32.3th percentile (776 hypotheses)

Tokens Used

KG Edges Generated

Citations Produced

Cost Ratios

Cost per KG Edge

0.00 tokens

Lower is better (baseline: 2000)

Cost per Citation

0.00 tokens

Lower is better (baseline: 1000)

Cost per Score Point

0.00 tokens

Tokens / composite_score

Score Impact

Efficiency Boost to Composite

+0.050

10% weight of efficiency score

Adjusted Composite

0.505

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for MMP9/HAS2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MMP9/HAS2 →

Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

KG Entities (25)

ARNTL CLOCK CSNK1D CSNK1E HAS2 IL1R1 MMP9 NFKB1 NLRP3 NR1D1 NR1D2 PER1 PPARGC1A PRKAA1 SIRT1 TNFRSF1A circadian_clock_entrainment circadian_disruption extracellular_matrix inflammatory_gene_expression

Related Hypotheses

Circadian Metabolic Reprogramming Therapy

Score: 0.455 | chronobiology

Clock Gene-Mediated Microglial Reprogramming

Score: 0.455 | chronobiology

Temporal Cytokine Receptor Modulation

Score: 0.455 | chronobiology

Microglial-Specific Circadian Gene Therapy

Score: 0.455 | chronobiology

Light-Independent Chronopharmacology

Score: 0.455 | chronobiology

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (20 edges)

Mechanism Pathway for MMP9/HAS2

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    ARNTL["ARNTL"] -->|transcriptionally| NLRP3["NLRP3"]
    NR1D1["NR1D1"] -->|represses| NFKB1["NFKB1"]
    IL1R1["IL1R1"] -->|mediates| microglial_priming["microglial_priming"]
    circadian_disruption["circadian_disruption"] -->|causes| neuroinflammation["neuroinflammation"]
    CSNK1D["CSNK1D"] -->|phosphorylates| PER1["PER1"]
    MMP9["MMP9"] -->|remodels| extracellular_matrix["extracellular_matrix"]
    IL1R1_1["IL1R1"] -->|modulates| positive_feedback_loops["positive_feedback_loops"]
    TNFRSF1A["TNFRSF1A"] -->|modulates| positive_feedback_loops_2["positive_feedback_loops"]
    circadian_disruption_3["circadian_disruption"] -->|causes| microglial_priming_4["microglial_priming"]
    SIRT1["SIRT1"] -->|regulates| microglial_metabolism["microglial_metabolism"]
    PRKAA1["PRKAA1"] -->|regulates| microglial_metabolism_5["microglial_metabolism"]
    PPARGC1A["PPARGC1A"] -->|regulates| microglial_metabolism_6["microglial_metabolism"]
    style ARNTL fill:#ce93d8,stroke:#333,color:#000
    style NLRP3 fill:#ce93d8,stroke:#333,color:#000
    style NR1D1 fill:#ce93d8,stroke:#333,color:#000
    style NFKB1 fill:#ce93d8,stroke:#333,color:#000
    style IL1R1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_priming fill:#4fc3f7,stroke:#333,color:#000
    style circadian_disruption fill:#4fc3f7,stroke:#333,color:#000
    style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
    style CSNK1D fill:#ce93d8,stroke:#333,color:#000
    style PER1 fill:#ce93d8,stroke:#333,color:#000
    style MMP9 fill:#ce93d8,stroke:#333,color:#000
    style extracellular_matrix fill:#81c784,stroke:#333,color:#000
    style IL1R1_1 fill:#ce93d8,stroke:#333,color:#000
    style positive_feedback_loops fill:#4fc3f7,stroke:#333,color:#000
    style TNFRSF1A fill:#ce93d8,stroke:#333,color:#000
    style positive_feedback_loops_2 fill:#4fc3f7,stroke:#333,color:#000
    style circadian_disruption_3 fill:#4fc3f7,stroke:#333,color:#000
    style microglial_priming_4 fill:#4fc3f7,stroke:#333,color:#000
    style SIRT1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_metabolism fill:#4fc3f7,stroke:#333,color:#000
    style PRKAA1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_metabolism_5 fill:#4fc3f7,stroke:#333,color:#000
    style PPARGC1A fill:#ce93d8,stroke:#333,color:#000
    style microglial_metabolism_6 fill:#4fc3f7,stroke:#333,color:#000

3D Protein Structure

🧬 MMP9 — PDB 1GKC Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Can circadian interventions reverse microglial priming independent of sleep disruption effects?

chronobiology | 2026-04-08 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (5)

Circadian Metabolic Reprogramming Therapy

Score: 0.46 · SIRT1/PRKAA1/PPARGC1A

Clock Gene-Mediated Microglial Reprogramming

Score: 0.46 · ARNTL/CLOCK

Temporal Cytokine Receptor Modulation

Score: 0.46 · IL1R1/TNFRSF1A

Microglial-Specific Circadian Gene Therapy

Score: 0.46 · ARNTL

Light-Independent Chronopharmacology

Score: 0.46 · CSNK1D/CSNK1E

→ View all analysis hypotheses

Circadian Extracellular Matrix Remodeling

Description

Dimension Scores

✓ Supporting Evidence 5

✗ Opposing Evidence 3

Novel The

Critical Evaluation of Therapeutic Hypotheses

1. Clock Gene-Mediated Microglial Reprogramming

7. Circadian Extracellular Matrix Remodeling

Price History

Clinical Trials (0)

📚 Cited Papers (8)

📅 Citation Freshness Audit

📙 Related Wiki Pages (0)

📓 Linked Notebooks (1)

⚔ Arena Performance

🔄 Related Hypotheses

Same Analysis (5)

🧬 Same Target Gene / Disease (6)

📊 Resource Economics & ROI

Cost Ratios

Score Impact

How Economics Pricing Works

📋 Reviews View all →

💬 Discussion

⚖️ Governance History

KG Entities (25)

Related Hypotheses

Estimated Development

🧪 Falsifiable Predictions

Knowledge Subgraph (20 edges)

causes (2)

inhibits (2)

maintains (1)

mediates (1)

modulates (5)

phosphorylates (1)

regulates (5)

remodels (1)

represses (1)

transcriptionally regulates (1)

Mechanism Pathway for MMP9/HAS2

3D Protein Structure

Source Analysis

Can circadian interventions reverse microglial priming independent of sleep disruption effects?

Community Feedback

Same Analysis (5)